Monkey pox 31 Aug 2022

Monkey pox

The EMA has recommended the approval of the smallpox vaccine Imvanex to protect against Monkeypox disease.

Monkeypox symptoms include head and muscle aches, exhaustion, fever and a rash. It can be fatal although it is typically milder than smallpox. Last month, the WHO declared the recent monkeypox outbreak, which began in May of this year, a global health emergency, therefore vaccination against the disease is very much in the news.

Smallpox vaccines were demonstrated through several observational studies to be about 85% effective in preventing monkeypox, according to the WHO. Imvanex has been approved in the EU since 2013 for protection against smallpox and as such is considered suitable as a monkeypox vaccine.

Several animal studies conducted by the EMA’s human medicine committee (CHMP) showed potential for human protection against the monkeypox virus and led them to conclude that it’s relatively risk free. They will conduct an observational study in Europe to confirm this.

Product information for Imvanex will be updated with information for healthcare professionals and the public, and an assessment report with details of EMA’s evaluation of the medicine will be published on their website.

Back to the list


COREX Logistics is a supply and logistics company with headquarters in Ireland, working with pharma and patients to facilitate improved healthcare worldwide.

Our expert international team works across an 80-country network, specialising in the EMEA region, providing the latest in clinical trial logistics technology and systems, cold-chain delivery, temperature-controlled transportation and storage services. From sourcing, procurement and customs clearance, to labelling, returns and destruction, we cover every link in the supply chain. We also run an established Named Patient Programme and provide Patient-Oriented services. With extensive knowledge and on-the-ground insight into our markets, we create innovative solutions with the ultimate goal of improving the lives of patients.

To learn more about our range of expert services, contact us today on

If you found this article helpful, consider sharing it with others who might also benefit from it. Sharing knowledge is a wonderful thing to do and can be very helpful to others.


We’re here to help.
Email us at or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.